Clinical trial
Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's…
NCT00075946 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00075946 |
|---|---|
| Title | Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma |
| Official title | Randomized Phase III Trial Comparing Two Different Rituximab Dosing Regimens For Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological |
| Interventions | rituximab |
| Enrollment | 545 |
| Start date | Jan 23, 2004 |
| Primary completion | Sep 1, 2013 |
| Completion | Aug 1, 2021 |
| First posted | Jan 14, 2004 |
| Last update posted | Feb 1, 2024 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: